With the PTAB soon to issue institution decisions on the controversial IPR petitions from the Coalition for Affordable Drugs and Ferro Ferrum Capital, patent owners have hit back through sanctions and additional discovery, and a complaint for attempted extortion
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
Firms that advise generics businesses reflect on whether they’re seeing more aggressive tactics from innovators and how they’re managing their practices
Ceyda Maisami explains why HP is becoming more vocal in its SEP arguments and reveals why the company has transformed the way it engages with outside counsel
In the latest UPC update, we examine a ruling on director liability, another on the Gillette defence, and look ahead to cases concerning medical devices
Lawyers at Dentons unpick the findings of a survey that revealed that businesses tend to focus on reactive rather than proactive use of AI when performing IP evaluations